Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 26/01/2012
PIL Aldactide 50 and 25 Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 25/09/2009 and displayed until 26/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 11/06/2008 and displayed until 25/09/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to date of revision
Updated on 02/01/2008 and displayed until 11/06/2008
Reasons for adding or updating:
  • Change to name of manufacturer
  • Change to date of revision
Updated on 27/07/2007 and displayed until 02/01/2008
Reasons for adding or updating:
  • Change from BAN to rINN
Updated on 21/06/2006 and displayed until 27/07/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 02/09/2004 and displayed until 21/06/2006
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 01/09/2004 and displayed until 02/09/2004
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 09/01/2001 and displayed until 01/09/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   spironolactone
   hydroflumethiazide